WindRose Health Investors Completes Majority Growth Investment in SubjectWell
New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision […]
SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification
The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment. AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which […]
SubjectWell Acquires PatientCentra
Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers […]
Why HCP outreach is so important for recruiting patients in rare disease
In rare disease trials, where patients are few and diagnosis is complex, trusted healthcare providers play a critical role in bridging the gap. This blog explores why HCP outreach is a powerful and often overlooked tool for patient recruitment, and how it can drive more qualified referrals and meaningful engagement.
SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market
SubjectWell Expands Executive Leadership to Realize Growth Strategy
AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor […]
Compensation norms create inequity in clinical trials
Exploring how compensation practices in clinical trials contribute to inequities and hinder diverse patient participation
US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations
AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient […]
How race and secondary conditions influence diabetes clinical trial interest
The impact of secondary conditions on clinical trial interest.
